Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neophytides

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
New York State Journal of Medicine|January 1, 1984
Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitorA N Lieberman, G Gopinathan, A Neophytides, et al.
Neurology|February 1, 1984
Combined use of benserazide and carbidopa in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
New York State Journal of Medicine|July 1, 1979
Huntington's diseaseA Lieberman, A Neophytides, I Casson, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Neurology|November 1, 1981
Lisuride combined with levodopa in advanced Parkinson diseaseA N Lieberman, M Goldstein, M Leibowitz, et al.
Lancet (London, England)|April 8, 1978
Long-term treatment of parkinsonism with bromocriptineD B Calne, C Plotkin, A C Williams, et al.
Neurology|August 1, 1981
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopaA Lieberman, M Goldstein, A Neophytides, et al.
The Medical Journal of Australia|November 4, 1978
Ergot derivatives for ParkinsonismD B Calne, A C Williams, J G Nutt, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
New York State Journal of Medicine|January 1, 1984
Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitorA N Lieberman, G Gopinathan, A Neophytides, et al.
Neurology|February 1, 1984
Combined use of benserazide and carbidopa in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
New York State Journal of Medicine|July 1, 1979
Huntington's diseaseA Lieberman, A Neophytides, I Casson, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Neurology|November 1, 1981
Lisuride combined with levodopa in advanced Parkinson diseaseA N Lieberman, M Goldstein, M Leibowitz, et al.
Lancet (London, England)|April 8, 1978
Long-term treatment of parkinsonism with bromocriptineD B Calne, C Plotkin, A C Williams, et al.
Neurology|August 1, 1981
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopaA Lieberman, M Goldstein, A Neophytides, et al.
The Medical Journal of Australia|November 4, 1978
Ergot derivatives for ParkinsonismD B Calne, A C Williams, J G Nutt, et al.
Pageof 4